[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343119-105":59,"doc-detail-343119-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-k9-lymphoma-assay-allows-a-genetic-subgrouping-of-canine-lymphomas-with-improved-risk-classification","The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification","","The K9 lymphoma assay presents a novel 31-gene targeted next-generation sequencing panel for genomic profiling of canine lymphoid neoplasms. It enables sensitive detection of actionable canine lymphoma mutations and assesses prognostic value to support diagnosis and prognosis. Analysis across B- and T-cell lymphoma histotypes reveals distinct mutational landscapes, shared origins between DLBCL and MZL, and subtype-spanning adverse impact from TP53. SETD2 links to shorter time-to-progression, while T-cell lymphomas show frequent SATB1 and FBXW7 mutations, guiding tailored therapy choices.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-k9-lymphoma-assay-allows-a-genetic-subgrouping-of-canine-lymphomas-with-improved-risk-classification/343119/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-k9-lymphoma-assay-allows-a-genetic-subgrouping-of-canine-lymphomas-with-improved-risk-classification/343119.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the K9 lymphoma assay and what does it measure?","Question",{"text":112,"@type":113},"It is a 31-gene targeted next-generation sequencing panel designed to profile genomic features of canine lymphoid neoplasms and to detect known actionable mutations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the results differ between B-cell and T-cell lymphoma histotypes?",{"text":117,"@type":113},"B-cell lymphomas show distinct mutational landscapes and prognostic impacts such as universal adverse effects from TP53, while T-cell lymphomas frequently harbor SATB1 and FBXW7 mutations.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genetic findings are linked to prognosis and progression?",{"text":121,"@type":113},"TP53 mutations have universal adverse prognostic implications across B-cell lymphomas, and SETD2 mutations are associated with shorter time-to-progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343119,1790470963,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification  \nAntonella Fanelli1, Luca Licenziato1, Eugenio Mazzone1, Sara Divari1, Andrea Rinaldi2, Michele Marino3, Ilaria Maga4, Francesco Bertoni2,5, Laura Marconato4* & Luca Aresu1*  \nWe present here the K9 lymphoma assay, a novel 31-gene targeted next-generation sequencing panel designed for genomic profiling of canine lymphoid neoplasms. Addressing the growing demand for advanced diagnostics in veterinary oncology, this assay enables sensitive identification of known and actionable mutations specific to canine lymphomas, while evaluating its prognostic potential to facilitate diagnosis and prognosis. Our analysis, spanning several B-and T-cell lymphoma histotypes, unveiled distinct mutational landscapes distinguishing tumors derived from immature versus mature lymphocytes. Clustering analysis revealed a shared genetic origin between diffuse large B-cell lymphoma and marginal zone lymphoma, aligning with findings in human lymphomas, with TRAF3 emerging as the most frequently mutated gene across B-cell lymphoma subtypes. Significantly, TP53 mutations demonstrated universal adverse prognostic implications across B-cell lymphomas. Additionally, SETD2 mutations contributed to shorter time-to-progression, underscoring the role of epigenetic dysregulation in B-cell tumors. InT-cell lymphomas, SATB1 and FBXW7 were frequently mutated, warranting further investigation in larger cohorts. Our findings advocate for tailored therapeutic approaches based on the genetic profile, impacting treatment decisions and outcomes incanine lymphoma management. This study provides pivotal insights bridging veterinary and human oncology, paving the way for comprehensive genomic diagnostics and therapeutic strategies in comparative oncology.  \nCanine nodal lymphomas arise from the malignant proliferation of lymphoid cells, primarily occurring within the lymph nodes, and they represent the most prevalent hematologic neoplasms in dogs1. The classification of canine lymphomas has evolved, and the World Health Organization (WHO) classification is now the widely adopted system2. The WHO classification categorizes canine lymphomas based on histologic and immunohistochemical criteria, sorting subtypes by morphologic and phenotypic features. Additionally, lymphomas are clinically divided into aggressive or indolent3.  \nApproximately 60–70% of canine lymphomas originate from B-cells, while the remaining cases derive from T-cells4. The most common aggressive B-cell lymphomas include diffuse large B-cell lymphoma (DLBCL), B-cell lymphoblastic lymphoma (B-LL) and Burkitt lymphoma (BL). Conversely, indolent B-cell lymphomas encompass follicular lymphoma (FL), marginal zone lymphoma (MZL), and B-cell small lymphocytic lymphoma (B-SLL) . Aggressive T-cell lymphomas comprise peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) and T-cell lymphoblastic lymphoma (T-LL), while T-zone lymphoma (TZL) and T-cell small lymphocytic lymphoma (T-SLL) are among the indolent forms.  \nWhile this classification system provides a framework for understanding and categorizing canine lymphomas based on morphological characteristics, it does not entirely elucidate the heterogeneity among tumor histotypes and their sensitivity to therapies. Despite the significant advancements in treatment protocols that have improved  \n1Department of Veterinary Sciences, University of Turin, Grugliasco, Turin, Italy. 2Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland. 3MyLav Veterinary Diagnostic Laboratory, Passirana di Rho, Milan, Italy. 4Department of Veterinary Medical Sciences, University of Bologna, Ozzanodell’Emilia, Bologna, Italy. 5Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. *email: [laura.marconato@unibo.it](laura.ma","cbCaib3nknQHtXZc","https://ap.wps.com/l/cbCaib3nknQHtXZc","pdf",2066606,13,"English","# Introduction\n## Canine nodal lymphoma and classification\n## Rationale for genomic profiling\n# The K9 lymphoma assay\n## Panel design and diagnostic aims\n## Findings from mutational and clustering analyses\n# Significance for veterinary and human oncology","[{\"question\":\"What is the K9 lymphoma assay and what does it measure?\",\"answer\":\"It is a 31-gene targeted next-generation sequencing panel designed to profile genomic features of canine lymphoid neoplasms and to detect known actionable mutations.\"},{\"question\":\"How do the results differ between B-cell and T-cell lymphoma histotypes?\",\"answer\":\"B-cell lymphomas show distinct mutational landscapes and prognostic impacts such as universal adverse effects from TP53, while T-cell lymphomas frequently harbor SATB1 and FBXW7 mutations.\"},{\"question\":\"Which genetic findings are linked to prognosis and progression?\",\"answer\":\"TP53 mutations have universal adverse prognostic implications across B-cell lymphomas, and SETD2 mutations are associated with shorter time-to-progression.\"}]","The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification | PDF",1790049978,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e70beb2ff3cfaf0393da91bd34906bd8.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3774f25d89da195e3536cfa6319e1fa0.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0f09a1c55b7c45b2152a1474ac68d4e.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3128930a35111fe85a9bc112d66524c8.webp",980,1287]